The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Prognostic Significance of Partial Tandem Duplications of the MLL Gene in Adult Patients 16 to 60 Years Old With Acute Myeloid Leukemia and Normal Cytogenetics: A Study of the Acute Myeloid Leukemia Study Group Ulm
Abstract
PURPOSE: To evaluate the incidence and clinical significance of partial tandem duplications (PTDs) of the mixed lineage leukemia (MLL) gene in a large series of newly diagnosed adult patients (16 to 60 years old) with acute myeloid leukemia (AML) intensively treated within the multicenter treatment trials AML-HD93 and AML-HD98A. PATIENTS AND METHODS: Identification of MLL PTD was performed centrally using Southern blot analysis in pretreatment samples from 525 of 683 assessable patients. PTD was confirmed by polymerase chain reaction (PCR) and sequencing of the PCR products. RESULTS: MLL PTD was identified in none of the 129 patients with t(8;21), inv(16), and t(15;17); in 19 (7.7%) of 247 patients with normal karyotype; and in 10 (8.5%) of 119 patients with all other abnormalities, with 30 cases of t(11q23) excluded. In the group of patients with a normal karyotype, there was no difference in the presenting clinical features between the PTD-positive and the PTD-negative cases. Sixteen (89%) of the 18 assessable PTD-positive patients and 158 (78%) of the 203 PTD-negative patients achieved a complete remission. After a median follow-up time of 19 months, 11 of the 16 PTD-positive patients relapsed compared with 54 of the 158 PTD-negative patients; the median remission durations of the PTD-positive and the PTD-negative groups were 7.75 months and 19 months, respectively (P < .001). Multivariate analysis identified the MLL PTD status as the single prognostic factor for remission duration. CONCLUSION: Within the subgroup of young adult AML patients with normal karyotype, MLL PTD is associated with short remission duration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
BENNETT, J. M., CATOVSKY, D., DANIEL, M. T., FLANDRIN, G., GALTON, D. A. G., GRALNICK, H. R., & SULTAN, C. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-4-620 · Cited by 2,926
Grimwade, D., Walker, H., Oliver, F., Wheatley, K., Harrison, C., Harrison, G., Rees, J., Hann, I., Stevens, R., Burnett, A., et al. (1998) · Blood · doi:10.1182/blood.v92.7.2322 · Cited by 2,655
Slovak, M. L., Kopecky, K. J., Cassileth, P. A., Harrington, D. H., Theil, K. S., Mohamed, A., Paietta, E., Willman, C. L., Head, D. R., Rowe, J. M., et al. (2000) · Blood · doi:10.1182/blood.v96.13.4075 · Cited by 1,601
Tkachuk, D. C., Kohler, S., & Cleary, M. L. (1992) · Cell · doi:10.1016/0092-8674(92)90602-9 · Cited by 920
Gu, Y., Nakamura, T., Alder, H., Prasad, R., Canaani, O., Cimino, G., Croce, C. M., & Canaani, E. (1992) · Cell · doi:10.1016/0092-8674(92)90603-a · Cited by 824
Cheson, B. D., Cassileth, P. A., Head, D. R., Schiffer, C. A., Bennett, J. M., Bloomfield, C. D., Brunning, R., Gale, R. P., Grever, M. R., & Keating, M. J. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.5.813 · Cited by 770
Bloomfield, C. D., Lawrence, D. D., Byrd, J. C., Carroll, A. J., Pettenati, M. J., Tantravahi, R. V., Patil, S., Davey, F. R., Berg, D. T., Schiffer, C. A., et al. (1998) · PubMed · Cited by 682
Thirman, M. J., Gill, H. J., Burnett, R. C., Mbangkollo, D., McCabe, N. R., Kobayashi, H., Ziemin-van der Poel, S., Kaneko, Y., Morgan, R., Sandberg, A. A., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199309233291302 · Cited by 502
Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics.
Caligiuri, M. A., Strout, M. P., Lawrence, D. D., Arthur, D., Baer, M., Yu, F., Knuutila, S., Mrózek, K., Oberkircher, A. R., Marcucci, G., et al. (1998) · PubMed · Cited by 224
Strout, M. P., Marcucci, G., Bloomfield, C. D., & Caligiuri, M. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2390 · Cited by 217
ALL-1 partial duplication in acute leukemia.
Schichman, S. A., Caligiuri, M. A., Gu, Y., Strout, M. P., Canaani, E., Bloomfield, C. D., & Croce, C. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.13.6236 · Cited by 207
Clinical importance of cytogenetics in acute myeloid leukaemia
Mrózek, K., Heinonen, K., & Bloomfield, C. D. (2001) · Best Practice & Research Clinical Haematology · doi:10.1053/beha.2000.0114 · Cited by 204
Caligiuri, M. A., Strout, M. P., Schichman, S. A., Mrózek, K., Arthur, D., Herzig, G. P., Baer, M., Schiffer, C. A., Heinonen, K., Knuutila, S., et al. (1996) · PubMed · Cited by 185
Bunjes, D., Buchmann, I., Duncker, C., Seitz, U., Kotzerke, J., Wiesneth, M., Dohr, D., Stefanic, M., Buck, A., Harsdorf, S. V., et al. (2001) · Blood · doi:10.1182/blood.v98.3.565 · Cited by 170
Censoring distributions as a measure of follow‐up in survival analysis
Korn, E. L. (1986) · Statistics in Medicine · doi:10.1002/sim.4780050306 · Cited by 166
Caligiuri, M. A., Schichman, S. A., Strout, M. P., Mrózek, K., Baer, M. R., Frankel, S. R., Barcos, M. P., Herzig, G. P., Croce, C. M., & Bloomfield, C. D. (1994) · PubMed · Cited by 159
Schnittger, S., Wormann, B. J., Hiddemann, W., & Griesinger, F. (1998) · Blood · doi:10.1182/blood.v92.5.1728 · Cited by 115
Fröhling, S., Skelin, S., Liebisch, C., Scholl, C., Schlenk, R. F., Döhner, H., & Döhner, K. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.155 · Cited by 109
Self-citationStrout, M. P., Marcucci, G., Caligiuri, M. A., & Bloomfield, C. D. (1999) · Annals of Hematology · doi:10.1007/s002770050511 · Cited by 61
Marcucci, G., Strout, M. P., Bloomfield, C. D., & Caligiuri, M. A. (1998) · PubMed · Cited by 60
Caligiuri, M. A., Strout, M. P., Oberkircher, A. R., Yu, F., de la Chapelle, A., & Bloomfield, C. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3899 · Cited by 52
Structure and expression of the human trithorax-like gene 1 involved in acute leukemias.
Parry, P. J., Djabali, M., Bower, M., Khristich, J. V., Waterman, M. L., Gibbons, B., Young, B. D., & Evans, G. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.10.4738 · Cited by 43
Schlenk, R. F., Hartmann, F., Hensel, M., Jung, W. E., Weber-Nordt, R., Gabler, A., Haas, R. R., Ho, A. D., Trümper, L. H. P., & Döhner, H. (2002) · Leukemia · doi:10.1038/sj.leu.2402423 · Cited by 19
Self-citation
Cited by
Cheson, B. D., Bennett, J. M., Kopecky, K. J., Büchner, T., Willman, C. L., Estey, E. H., Schiffer, C. A., Doehner, H., Tallman, M. S., Lister, T. A., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.036 · Cited by 2,654
Creutzig, U., & Kaspers, G. J. L. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.99.116 · Cited by 2,137
Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia
Schlenk, R. F., Döhner, K., Krauter, J., Fröhling, S., Corbacioglu, A., Bullinger, L., Habdank, M., Späth, D., Morgan, M., Benner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074306 · Cited by 1,628
Self-citationEstey, E., & Döhner, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69780-8 · Cited by 1,296
Self-citationUse of Gene-Expression Profiling to Identify Prognostic Subclasses in Adult Acute Myeloid Leukemia
Bullinger, L., Döhner, K., Bair, E., Fröhling, S., Schlenk, R. F., Tibshirani, R., Döhner, H., & Pollack, J. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031046 · Cited by 993
Self-citation
Metadata
- Authors
- Döhner, K., Tobis, K., Ulrich, R., Fröhling, S., Benner, A., Schlenk, R. F., & Döhner, H.
- Venue
- Journal of Clinical Oncology
- Published
- 2002-08-01
- Volume
- 20
- Issue
- 15
- Pages
- 3254-3261
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2129291113
- Cited by
- 322
- References
- 28
- FWCI
- 7.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.